Recent layoffs seemed to focus on the over forty age groups. Being a sales rep in certain regions will be harder due to poor access to customers. Products are good but are aging and facing plenty of generic and me-too product competition, which means more micro-management as profits taper off. This it typical of many big pharma Co's. They have a good future pipeline, but introduction time lines are a guessing game.